A 62-year-old inpatient with initial CDI responds to fidaxomicin. He has high recurrence risk. Which adjunct is suggested for prevention of recurrence...

Question

A 62-year-old inpatient with initial CDI responds to fidaxomicin. He has high recurrence risk. Which adjunct is suggested for prevention of recurrence?

Accepted Answer

Bezlotoxumab one-time infusion

Answer

Probiotic yeast

Answer

Cholestyramine

Answer

IVIG weekly

Answer

Rifaximin chaser for all patients

us-abim MCQ (SBA): C. difficile Recurrence Prevention

A 62-year-old inpatient with initial CDI responds to fidaxomicin. He has high recurrence risk. Which adjunct is suggested for prevention of recurrence?